Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution)
1.5% will have an effect on contact lens wear in patients with contact lens intolerance due
to allergic conjunctivitis.